DK116752B - Process for the preparation of an injectable influenza vaccine composition. - Google Patents

Process for the preparation of an injectable influenza vaccine composition.

Info

Publication number
DK116752B
DK116752B DK457667AA DK457667A DK116752B DK 116752 B DK116752 B DK 116752B DK 457667A A DK457667A A DK 457667AA DK 457667 A DK457667 A DK 457667A DK 116752 B DK116752 B DK 116752B
Authority
DK
Denmark
Prior art keywords
preparation
vaccine composition
influenza vaccine
injectable influenza
injectable
Prior art date
Application number
DK457667AA
Other languages
Danish (da)
Inventor
Group Ltd Beecham
Original Assignee
Group Ltd Beecham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Group Ltd Beecham filed Critical Group Ltd Beecham
Publication of DK116752B publication Critical patent/DK116752B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK457667AA 1966-09-13 1967-09-12 Process for the preparation of an injectable influenza vaccine composition. DK116752B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40770/66A GB1128637A (en) 1966-09-13 1966-09-13 Influenza vaccine

Publications (1)

Publication Number Publication Date
DK116752B true DK116752B (en) 1970-02-09

Family

ID=10416528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457667AA DK116752B (en) 1966-09-13 1967-09-12 Process for the preparation of an injectable influenza vaccine composition.

Country Status (9)

Country Link
AT (1) AT270069B (en)
BE (1) BE703831A (en)
DE (1) DE1617357A1 (en)
DK (1) DK116752B (en)
ES (1) ES344982A1 (en)
FR (1) FR6798M (en)
GB (1) GB1128637A (en)
NL (1) NL6712552A (en)
SE (1) SE320764B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407522A (en) * 1983-03-11 1983-10-04 Hyman Suroff Energy saving ice skate attachment device
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation

Also Published As

Publication number Publication date
ES344982A1 (en) 1968-11-16
DE1617357A1 (en) 1971-03-25
SE320764B (en) 1970-02-16
BE703831A (en) 1968-03-13
AT270069B (en) 1969-04-10
GB1128637A (en) 1968-09-25
NL6712552A (en) 1968-03-14
FR6798M (en) 1969-03-17

Similar Documents

Publication Publication Date Title
DK133618B (en) Analogous process for the preparation of 1-hydroxyaryl-2-aminoalkanols.
DK117896B (en) Analogous process for the preparation of 17-esters of 21-deoxyprednisolone.
DK119111B (en) Process for the preparation of oxazolidinone derivatives.
DK121454B (en) Process for the preparation of an excipient-containing vaccine.
DK119724B (en) Process for the preparation of an antigen-free vaccine.
DK124886B (en) Process for the preparation of 1-hydroxy-benzimidazole-N-oxides.
DK117954B (en) Process for the preparation of 3-amino-2-cyanoacrylamide.
DK126584B (en) Process for the preparation of D-2-phenoxypropionic acids.
DK110208C (en) Process for the preparation of influenza vaccines.
DK116752B (en) Process for the preparation of an injectable influenza vaccine composition.
DK119939B (en) Process for the preparation of tetanus vaccine.
DK115551B (en) Process for the preparation of 6-aminouracil-5-carbonamide-N-sulfonamides.
DK113866B (en) Process for the preparation of somatic antigen vaccines.
DK129004B (en) Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series.
DK119219B (en) Process for the preparation of an oral or injectable penicillin preparation.
DK120344B (en) Process for the preparation of 5-benzyl-pyrimidines.
DK114063B (en) Process for the preparation of 1-methyl-2-isopropyl-5-nitro-imidazole.
DK114626B (en) Process for the preparation of 2-substituted-4-amino-5-acylamidomethylpyrimidine.
DK121706B (en) Process for the preparation of monothioether glycol.
DK124401B (en) Analogous process for the preparation of benzenesulfonylureas.
DK121165B (en) Process for the preparation of 1-aminoalkyl-1-arylindenar or 3-aminoalkyl-3-arylindan-1-ols.
DK119830B (en) Analogous process for the preparation of arylsulfonylsemicarbazides.
DK126378B (en) Analogous process for the preparation of 17α-acyloxy-9α-chloro-11β-hydroxy-progesterones.
DK124405B (en) Process for the preparation of 2-trifluoromethyl- or 2-pentafluoroethyl-benzimidazoles.
DK116733B (en) Process for the preparation of steroid-17-butenolides.